Barış Çıplak

Dr. Barış Çıplak

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2022 in Paramedik ve Acil Sağlık Hizmetleri Dergisi
Verified
Journal Article
Closed access
PDF file
SASümeyye Ahi̇
Sümeyye Ahi̇
BÇBarış Çıplak
Barış Çıplak
ABArda Borlu
Arda Borlu
HAHalime Aydemir
Halime Aydemir
FEFatma ERGÜN
Fatma ERGÜN
Çalışmada Sağlık Bilimleri Fakültesi öğrencilerinin COVID-19 korku düzeylerinin ve ilişkili faktörlerin belirlenmesi amaçlanmıştır. Tanımlayıcı nitelikte olan bu çalışma bir üniversitenin Sağlık Bilimleri Fakültesi’nde öğrenim gören olasılıksız örnekleme yöntemi ile seçilen 341 gönüllü öğrencinin katılımıyla tamamlanmıştır. Veri toplama aracı olarak anket formu ve Koronavirüs Korku Ölçeği kullanılmış olup anket formu ve Koronavirüs Korku Ölçeği internet ortamında hazırlanıp sosyal medya üzerinden öğrencilere link gönderilerek gerçekleştirilmiştir. Araştırma için etik kurul ve kurum izni alınmıştır. Verilerin değerlendirilmesinde Kolmogorov-Smirnov, Shapiro-Wilk, t-testi, One Way Anova, Post Hoc testi olarak LCD kullanılmıştır. Öğrencilerin yaş ortalaması 21,19±0,13 yıl, %8,2’si erkek, %78,3’ü kentsel bölgede yaşamakta, %12,6’sı sigara içmekte, %8,2’si alkol tüketmekte ve %8,8’inin kronik hastalığı mevcut olup %9,1’i sürekli ilaç kullanmaktadır. Öğrencilerin Koronavirüs Korku Ölçeğinden aldıkları puan ortalaması 17,70±5,84’tür. Ekonomik durumunu kötü olarak ifade eden ve COVID-19 ile ilgili haberleri takip eden öğrencilerin koronavirüs korku düzeyleri daha yüksek bulunurken, sigara kullanımı, yakınında COVID-19 tanısı almış birey bulunma ve ailede 65 yaş ve üstü birey olma durumu ile koronavirüs korku düzeyi arasında fark bulunmamıştır. Konuyla ilgili diğer çalışmalara benzer şekilde Sağlık Bilimleri Fakültesi öğrencilerinin koronavirüs korkusunun orta düzeyde olduğu ve ekonomik durum ile çeşitli haber kaynaklarının takibinin koronavirüs korkusunu arttırdığı bulunmuştur. Çalışmanın sonlandırıldığı tarihten sonra dünya genelinde ve Türkiye’de görülen vaka artışlarının öğrencilerin korku düzeylerinde bir değişikliğe yol açıp açmadığını ortaya koyacak yeni çalışmaların yapılması faydalı olacaktır.

1 January 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
BÇBarış Çıplak
Barış Çıplak
ETEyup Gokhan Turmus
Eyup Gokhan Turmus
OKOzlem Kara
Ozlem Kara
GDGulcin Daglioglu
Gulcin Daglioglu
MAMehmet Murat Altindag
Mehmet Murat Altindag
MKMustafa Kara
Mustafa Kara
The objective of this study was to investigate the protectiveness of resveratrol on cisplatin-induced damage to the ovary using experimental models.

1 April 2022 in Journal of Surgery and Medicine
Verified
Journal Article
Open access
PDF file
ABAyse Gulcin Bastemur
Ayse Gulcin Bastemur
BÇBarış Çıplak
Barış Çıplak
Rauf MelekogluRauf Melekoglu
Rauf Melekoglu
STSerhat Toprak
Serhat Toprak
CKCemalettin Koç
Cemalettin Koç
EYErcan Yilmaz
Ercan Yilmaz
Background/Aim: Ovarian cancer is the second most common gynecologic malignancy worldwide and is the deadliest among gynecological cancers. It is important that this cancer, which is usually diagnosed in advanced stages, is referred to a gynecologist oncologist without delay. An ideal screening method does not yet exist. Although CA 125 is still the most used tumor marker, it cannot detect early-stage ovarian cancer. Also, CA 125 is not specific for ovarian malignancy. Therefore, new serum markers, such as HE4, and more complex algorithms, like ROMA and RMI, have emerged. Here we evaluate the preoperative potential of patients with adnexal mass to have a malignant or benign mass with morphological index, CA 125, HE4, RMI, and ROMA tests. Methods: This study is a prospective cohort study. A power analysis was done before starting the study. The sample size was at least 80 when the Type I error was set at 0.05, and the confidence interval was 95%. We included into the study 84 patients admitted to our clinic because of pelvic mass and underwent operation between March 2016 and October 2018. To homogenize the benign and malignant groups, 42 patients were collected from each group. CA 125 and HE4 levels of the samples were studied by the electrochemiluminescence method. ROMA and RMI values were calculated, and the data were entered into SPSS. Data were analyzed using SPSS 22.0 statistical package program. Results: Each of the CA 125 (P = 0.002), HE4 (P < 0.001), morphological index (P < 0.001), ROMA (P < 0.001), and RMI (P < 0.001) tests has been successful in differentiating malignant masses from benign masses. In the malignant-benign differentiation of adnexal masses preoperatively, CA 125 was the test with the lowest sensitivity, and RMI had the highest sensitivity. However, in the ROC analysis, the morphological index has a higher area under the curve. Conclusion: Although CA 125 is still the most frequently used marker in the preoperative evaluation of adnexal masses, it has low specificity and sensitivity, especially in premenopausal patients. The use of new tumor markers (e.g., HE4) and other algorithms (e.g., ROMA and RMI) is supported by our findings and the literature. However, here we show that an expert ultrasonographic evaluation with morphological index alone could be effective.

21 January 2025
Verified
Book
Open access
PDF file
SBSelda Bayat Balkan
Selda Bayat Balkan
SASertaç Ayçiçek
Sertaç Ayçiçek
ESEsra Söylemez
Esra Söylemez
UEUmut Erkök
Umut Erkök
GBGizem Berfin Uluutku Bulutlar
Gizem Berfin Uluutku Bulutlar
CUCan Ozan Ulusoy
Can Ozan Ulusoy

Verified
Journal Article
Open access
PDF file
STSeyhmus Tunç
Seyhmus Tunç
KAKevser Arkan
Kevser Arkan
HKHuseyin Kayaalp
Huseyin Kayaalp
ABAdnan Budak
Adnan Budak
AEAli Deniz Erkmen
Ali Deniz Erkmen
SASedat Akgol
Sedat Akgol
Background: While maternal obesity is a well-established risk factor for labor induction failure, the specific impact of regional fat distribution and its direct influence on prostaglandin dose–response profiles remain under-investigated. Relying solely on generalized anthropometric metrics like Body Mass Index (BMI) may obscure the true physiological variations in tissue bioavailability. Therefore, this study aimed to compare dinoprostone-induced labor outcomes between obese pregnant women and non-obese controls, and to evaluate whether ultrasonographically measured abdominal subcutaneous fat thickness (ASFT) can serve as a more precise, independent predictor of induction success and cumulative prostaglandin dose requirements. Methods: This prospective two-center observational study was conducted with 200 single-term pregnant women, comprising an obese study group (n = 100, BMI ≥ 30 kg/m2) and a symmetrical non-obese control group (n = 100, BMI 18.5–29.9 kg/m2). Maternal ASFT was measured via high-resolution ultrasonography at the infraumbilical midline prior to labor induction. All participants initially received a 10 mg dinoprostone vaginal insert governed by a standardized institutional induction protocol. Primary outcomes included successful labor induction (defined as achieving vaginal delivery within 24 h) and cumulative prostaglandin dose requirements. Secondary analyses involved comparative evaluation stratified by obesity classes (Class 1 vs. Class 2–3) and an exploratory ASFT threshold (<30 mm vs. ≥30 mm). Results: Obese women demonstrated significantly lower successful labor induction rates (defined as vaginal delivery within 24 h) compared to the non-obese control group (59.0% vs. 86.0%, p = 0.001). The cumulative dinoprostone dose required for cervical ripening was significantly higher in the obese cohort than in controls (16.8 ± 4.5 mg vs. 12.4 ± 2.2 mg, p < 0.001). Similarly, induction-to-delivery intervals were significantly prolonged in obese parturients (19.2 ± 6.1 vs. 14.6 ± 4.8 h, p < 0.001). Subgroup analysis within the obese cohort revealed that patients with ASFT ≥ 30 mm required higher prostaglandin doses (18.08 ± 3.40 mg vs. 14.14 ± 3.08 mg, p < 0.001) and exhibited lower vaginal delivery rates (45.7% vs. 70.4%, p = 0.012) than those with ASFT < 30 mm. Multivariate logistic regression analysis encompassing the entire study population (n = 200) confirmed that ASFT remained a strong independent predictor of induction failure (Adjusted OR: 1.14; 95% CI: 1.05–1.24, p = 0.002). Conversely, generalized obesity metrics via BMI did not maintain independent significance in the multivariate model (p = 0.420). Conclusions: Increased maternal ASFT is directly associated with blunted drug responsiveness, higher cumulative dinoprostone requirements, and a lower likelihood of successful labor induction. Compared with generalized metrics such as BMI, ultrasonographic measurement of ASFT provides a more precise and clinically relevant assessment of regional maternal adiposity. These findings suggest that incorporating pre-induction ASFT evaluation into routine obstetric practice could improve risk stratification and help clinicians design individualized, precision-based dosing strategies for obese parturients.

1 January 2022 in Medicine Science | International Medical Journal
Verified
Journal Article
Open access
BÇBarış Çıplak
Barış Çıplak
YSYahya Sahin
Yahya Sahin
RARukiye Akyol
Rukiye Akyol
FSFikriye Sezgin
Fikriye Sezgin
LHLokman Hizmali
Lokman Hizmali
MKMustafa Kara
Mustafa Kara
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can potentially infect female reproductive organs. In this study, we investigated the presence of SARS-CoV-2 in cervicovaginal fluid. This study included 31 female patients aged 18–65 years. The presence of SARS-CoV-2 RNA was investigated by RT‒PCR in two separate cervicovaginal swab samples collected from patients 14 days apart. Viral RNA was extracted using Bio-Speedy ®vNAT® Viral Nucleic Acid Buffer (vNAT) solution, and SARS-CoV-2 RNA was analyzed using Bio-Speedy SARS-CoV-2 RT‒qPCR kits in a Bio-Rad CFX96 TouchTM device. First and second cervical swab samples were collected 14 days apart. The SARS-CoV-2 RNA result was negative in all 53 cervicovaginal swab samples collected. Negative SARS-CoV-2 RNA results in cervicovaginal swab samples indicate that coronavirus disease 2019 (COVID-19) is not sexually transmitted. However, the number of studies on this subject and the sample size examined are still insufficient for reaching this conclusion.